Back

The BET protein inhibitor apabetalone (RVX-208) prevents doxorubicin-induced endothelial senescence

31 August 2024 (16:00 - 16:50)
Organised by: Logo
Congress Presentation Part of: Novel insights into ageing and senescence Stem Cells, Cell Cycle, Cell Senescence, Cell Death ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Shafeeq Ahmed Mohammed

University Hospital Zurich, Zurich (Switzerland)

8 More presentations in this session

Presentation thumbnail
The effect of CD38 inhibition in age-associated vascular dysfunction
Doctor Y. Puspitasari (Schlieren, CH)
Abstract Slides Video
Presentation thumbnail
The role of cellular senescence in aortic dissection
Doctor E. Nakao (Kurume, JP)
Abstract Slides Video
Presentation thumbnail
Non-cell-autonomous effects of arginase-II in macrophages on cardiomyocytes in aging
Doctor D. Potenza (Fribourg, CH)
Abstract Slides Video
Presentation thumbnail
Sirt5 as a mediator of endothelial and vascular dysfunction: potential therapeutic target in aging-related vascular diseases
Doctor K. Yang (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
Digoxin reduces senescence and restores dysfunctional endothelial-subcutaneous adipocyte cross-talk and dysregulated glucose homeostasis in patients with type 2 diabetes mellitus
Doctor O. Brown (Leeds, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Novel insights into ageing and senescence

The Event

Event poster

ESC Congress 2024

31 August 2024 16:00 CET
You may be interested in
thumbnail
Congress Presentation
Epigenetic editing of chromatin readers rescues doxorubicin-induced endothelial senescence and vascular dysfunction
thumbnail
Congress Session
Epigenetic targets in cardiovascular disease
thumbnail
Congress Session
Molecular mechanisms of cardiovascular ageing: from senescence to regeneration

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources